Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents

Published:2023-08 Issue: Volume:1286 Page:135626
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Kuran Ebru Didem^ORCID,Dincel Efe Doğukan^ORCID,Biltekin Sevde Nur^ORCID,Akalın-Çiftçi Gülşen,Ulusoy-Güzeldemirci Nuray

Funder

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference31 articles.

1. Insights on fluoroquinolones in cancer therapy: chemistry and recent developments;Sharma;Materials Today Chemistry,2020

2. The global burden of cancer, Best practice & research;Popat;Clinical anaesthesiology,2013

3. Early detection of lung cancer biomarkers through biosensor technology: A review;Roointan;Journal of pharmaceutical and biomedical analysis,2019

4. Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment;Kulkarni;European Journal of Pharmaceutical Sciences,2019

5. Design, synthesis, in vitro, and in silico studies of novel benzylidene 6-methoxy-1-tetralone linked to benzyloxy and benzyl-1, 2, 3-triazole rings as potential tyrosinase inhibitors;Najafi;Journal of Molecular Structure,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitargeted molecular docking and dynamics simulation studies of 1,3,4-thiadiazoles synthesised from (R)-carvone against specific tumour protein markers: An In-silico study of two diastereoisomers;Computational Biology and Chemistry;2024-10

2. Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors;Journal of Molecular Structure;2024-09

3. Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023);Expert Opinion on Therapeutic Patents;2024-07-03